Can we reduce the incidence of second primary malignancies occurring after radiotherapy?

Radiotherapy and Oncology

Volumn 91, Issue 1, 2009, Pages 1-3

  Trott, Klaus Rüdiger ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; EDITORIAL; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION EXPOSURE; SECOND CANCER; UTERINE CERVIX CANCER;

EID: 62549129470     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.01.007     Document Type: Editorial

References (11)

1. Suit H., Goldberg S., Niemierko A., et al. Secondary carcinogenesis in patients treated with radiation. A review of data on radiation-induced cancers inhuman, non-human primate, canine and rodent subjects. Radiat Res 167 (2007) 12-42
2. Xu X.G., Bednarz B., and Paganetti H. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol 53 (2008) R193-R241
3. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91 (2009) 4-15
4. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
5. Kry S.F., Salehpour M., Followill D., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195-1203
6. Schneider U., Zwahlen D., Ross D., et al. Estimation of radiation induced cancer from 3D-dose distributions. Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 61 (2005) 1510-1515
7. Ruben J.D., Davis S., Evans C., et al. The effect of intensity modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys (2008) 1530
8. Tubiana M. Late mortality in Hodgkińs disease: can we reduce it?. Ann Oncol Suppl. 1 (2002) 5-9
9. Tubiana M, Henry-Amar M, Cardie P et al. Towards comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkińs disease. The EORTC Lymphoma Group controlled clinical trials 1964-1987. Blood 1993;73:47-56.
10. Cosset JM. Annual meeting of ESTRO 2008, Radiother Oncol Suppl, [abstract nr].
11. Trott KR. Second cancers after radiotherapy. In: van der Kogel, Joiner, editors. Basic clinical radiobiology. London:Hodder publ; 2009.